UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

How I treat the acquired von Willebrand syndrome

Blood, 2011-06, Vol.117 (25), p.6777-6785

2011

Volltextzugriff (PDF)

Clinical and laboratory diagnosis of VWD

Hematology, 2014-12, Vol.2014 (1), p.524-530

Federici, Augusto B

2014

Volltextzugriff (PDF)

Activation-independent platelet adhesion and aggregation under elevated shear stress

Blood, 2006-09, Vol.108 (6), p.1903-1910

2006

Volltextzugriff (PDF)

Current Diagnosis of von Willebrand Disease in Italy: 3 Years Following the Release of the International Guidelines

Seminars in thrombosis and hemostasis, 2024-07

Federici, Augusto B.

2024

Volltextzugriff (PDF)

VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease

Blood, 2013-03, Vol.121 (12), p.2336-2339

2013

Volltextzugriff (PDF)

Von Willebrand Disease: Gaining a global perspective

Haemophilia : the official journal of the World Federation of Hemophilia, 2023-07, Vol.29 (4), p.1104-1112

2023

Volltextzugriff (PDF)

Real-World Efficacy and Safety of Plasma-Derived Von Willebrand Factor-Containing Factor VIII Concentrates in Patients With Von Willebrand Disease in Italy

Clinical and applied thrombosis/hemostasis, 2024-01, Vol.30, p.10760296241264541

2024

Volltextzugriff (PDF)

An intact PDZ motif is essential for correct P2Y12 purinoceptor traffic in human platelets

Blood, 2011-11, Vol.118 (20), p.5641-5651

2011

Volltextzugriff (PDF)

Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel

American journal of obstetrics and gynecology, 2009-07, Vol.201 (1), p.12.e1-12.e8

2009

Volltextzugriff (PDF)

HDL/ApoA-I: role in VWF-dependent thrombosis

Blood, 2016-02, Vol.127 (5), p.526-528

Federici, Augusto B.

2016

Volltextzugriff (PDF)

Type 2B von Willebrand Disease: A Matter of Plasma Plus Platelet Abnormality

Seminars in thrombosis and hemostasis, 2016-07, Vol.42 (5), p.478-482

2016

Volltextzugriff (PDF)

Current diagnostic and therapeutic approaches to patients with acquired von Willebrand syndrome: a 2013 update

Seminars in thrombosis and hemostasis, 2013-03, Vol.39 (2), p.191-201

2013

Volltextzugriff (PDF)

The bleeding score predicts clinical outcomes and replacement therapy in adults with von Willebrand disease

Blood, 2014-06, Vol.123 (26), p.4037-4044

2014

Volltextzugriff (PDF)

The impact of bleeding history, von Willebrand factor and PFA–100® on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM‐1VWD

British journal of haematology, 2010-11, Vol.151 (3), p.245-251

2010

Volltextzugriff (PDF)

Clinical and laboratory versus molecular markers for a correct classification of von Willebrand disease

Haematologica (Roma), 2009-05, Vol.94 (5), p.610-615

2009

Volltextzugriff (PDF)

Towards a more automatic and rapid laboratory diagnosis of von Willebrand disease

Thrombosis research, 2016-05, Vol.141, p.198-201

Federici, Augusto B

2016

Volltextzugriff (PDF)

Clinical use of Haemate(R) P in inherited von Willebrand's disease: a cohort study on 100 Italian patients

Haematologica (Roma), 2007-07, Vol.92 (7), p.944-951

2007

Volltextzugriff (PDF)

Evaluation and management of postpartum hemorrhage: consensus from an international expert panel

Transfusion, 2014-07, Vol.54 (7), p.1756-1768

2014

Volltextzugriff (PDF)

A need to increase von Willebrand disease awareness: vwdtest.com – A global initiative to help address this gap

Blood reviews, 2023-03, Vol.58, p.101018-101018, Article 101018

2023

Volltextzugriff (PDF)

Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus

Blood transfusion = Trasfusione del sangue, 2019-05, Vol.17 (3), p.171-180

2019

Volltextzugriff (PDF)

Premature termination codon mutations in the von Willebrand factor gene are associated with allele-specific and position-dependent mRNA decay

Haematologica (Roma), 2010-01, Vol.95 (1), p.172-174

2010

Volltextzugriff (PDF)

Activated prothrombin complex concentrate (FEIBA®) in acquired haemophilia A: a large multicentre Italian study – the FAIR Registry

British journal of haematology, 2019-03, Vol.184 (5), p.853-855

2019

Volltextzugriff (PDF)

Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients

Blood, 2009-01, Vol.113 (3), p.526-534

2009

Volltextzugriff (PDF)

An association of candidate gene haplotypes and bleeding severity in von Willebrand disease (VWD) type 1 pedigrees

Blood, 2004-10, Vol.104 (8), p.2359-2367

2004

Volltextzugriff (PDF)

1 – 25 von 213

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(179)
Mit Volltextzugriff
(178)

Publikationsform

Sprache

Englisch
(213)

Erscheinungsjahr

n.n

Thema

Humans
(125)
Science & Technology
(104)
Life Sciences & Biomedicine
(103)
Hematology
(91)
Biological And Medical Sciences
(60)
Medical Sciences
(56)
Von Willebrand Factor
(54)
Female
(47)
Von Willebrand Disease
(45)
Hematologic And Hematopoietic Diseases
(43)
Male
(41)
Von Willebrand Diseases - Diagnosis
(37)
Platelet Diseases And Coagulopathies
(36)
Adult
(29)
Von Willebrand Factor - Metabolism
(29)
Von Willebrand Diseases - Genetics
(28)
Middle Aged
(26)
Von Willebrand Diseases - Therapy
(26)
Von Willebrand Diseases - Drug Therapy
(25)
Cardiovascular System & Cardiology
(24)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

How I treat the acquired von Willebrand syndrome

Clinical and laboratory diagnosis of VWD

Activation-independent platelet adhesion and aggregation under elevated shear stress

Current Diagnosis of von Willebrand Disease in Italy: 3 Years Following the Release of the International Guidelines

VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease

Von Willebrand Disease: Gaining a global perspective

Real-World Efficacy and Safety of Plasma-Derived Von Willebrand Factor-Containing Factor VIII Concentrates in Patients With Von Willebrand Disease in Italy

An intact PDZ motif is essential for correct P2Y12 purinoceptor traffic in human platelets

Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel

HDL/ApoA-I: role in VWF-dependent thrombosis

Type 2B von Willebrand Disease: A Matter of Plasma Plus Platelet Abnormality

Current diagnostic and therapeutic approaches to patients with acquired von Willebrand syndrome: a 2013 update

The bleeding score predicts clinical outcomes and replacement therapy in adults with von Willebrand disease

The impact of bleeding history, von Willebrand factor and PFA–100® on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM‐1VWD

Clinical and laboratory versus molecular markers for a correct classification of von Willebrand disease

Towards a more automatic and rapid laboratory diagnosis of von Willebrand disease

Clinical use of Haemate(R) P in inherited von Willebrand's disease: a cohort study on 100 Italian patients

Evaluation and management of postpartum hemorrhage: consensus from an international expert panel

A need to increase von Willebrand disease awareness: vwdtest.com – A global initiative to help address this gap

Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus

Premature termination codon mutations in the von Willebrand factor gene are associated with allele-specific and position-dependent mRNA decay

Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)

Activated prothrombin complex concentrate (FEIBA®) in acquired haemophilia A: a large multicentre Italian study – the FAIR Registry

Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients

An association of candidate gene haplotypes and bleeding severity in von Willebrand disease (VWD) type 1 pedigrees

Suchergebnisse filtern